Form D · Other Health Care

Next Frontier Biosciences, Inc.

Westminster, CO · CIK 0001628804

Offering snapshot reported Jan 24, 2020 · SEC filing

Reported sold
$826K
Offering amount: $1.2M
Investors reported
27
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 9, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 24, 2020Initial$825,601No comparison27SEC filing
Jan 9, 2019Amendment$2,851,633$2,101,426vs Sep 1, 201720SEC filing
Sep 1, 2017Initial$750,207No comparison12SEC filing
May 26, 2017Amendment$1,785,119$225,000vs Apr 4, 201714SEC filing
Apr 4, 2017Initial$1,560,119No comparison11SEC filing
Oct 5, 2016Initial$850,000No comparison4SEC filing
Apr 25, 2016Amendment$1,250,011$500,005vs Sep 4, 201522SEC filing
Sep 4, 2015Initial$750,006No comparison11SEC filing
Dec 22, 2014Initial$1,114,330No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-358921
Offer and Sale of Preferred Stock (and the Common Stock issuable thereunder)

Source: Form D, filed Jan 24, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc Graboyes Director, Executive, Promoter
Paul Johnson Director
Peter Johnson Promoter
James Kreitman Director
Charles Sander Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
6510 W. 91st Avenue, Suite 106
Westminster, CO, 80031